PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-03-13

Date Title Company
13-Mar-2025 ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP ViiV Healthcare
13-Mar-2025 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Genmab
13-Mar-2025 Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab Genmab
13-Mar-2025 Global leader in fluoroproducts shortlisted for three awards Orbia Fluor & Energy Materials
13-Mar-2025 Amavita Heart and Vascular Health™ Elevates Quality Standards and Achieves ‘Center of Excellence Status’ for Clinical Research in the Cardiovascular Field IAOCR
13-Mar-2025 DNA Methylation Detection Technology Market Size to Reach USD 10,512.0 Million in 2032 Navistrat Analytics
13-Mar-2025 Achieving ASMF Compliance with Proregulations' Strategic Approach Proregulations
13-Mar-2025 Proregulations' Comprehensive EU MAA Solutions Proregulations
13-Mar-2025 Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty Heidelberg Pharma AG
13-Mar-2025 Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results Nyxoah SA.
13-Mar-2025 DocMorris achieves 2024 targets, expects Rx growth of around 50 per cent in the first quarter of 2025 and plans capital increase DocMorris AG